Getinge exits surgical perfusion, creating opportunity for Livanova

Getinge CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced the company off the U.S. market in 2015.

By Nick Paul Taylor • Jan. 30, 2025

White House rescinds memo pausing federal funding following pushback

The Office of Management and Budget rolled back a memo halting federal funding that caused widespread confusion and alarm. But “this is NOT a rescission of the federal funding freeze,” Trump’s top press secretary said.

By Rebecca Pifer • Jan. 29, 2025

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

Stryker to sell spinal implants business

The company named a new CFO and shared an update on its planned Inari Medical acquisition.

By Elise Reuter • Jan. 29, 2025

4 robotic surgery trends to watch in 2025

Intuitive Surgical will face competition this year from Medtronic and smaller companies like CMR Surgical and Moon Surgical coming to the U.S. market with robotic surgery systems.

By Susan Kelly • Jan. 29, 2025

Lawmakers report states shut out of Medicaid payment portals following Trump funding freeze

Other payment systems also appear to be offline, suggesting a broader shutdown of federal portals related to grants and funding.

By Rebecca Pifer • Updated Jan. 28, 2025

Trump freezes federal grants with big potential impact on providers, Medicaid

Federal agencies must stop disbursing financial assistance starting at 5 p.m. today under a new budget directive, threatening funding for providers and creating significant uncertainty for Medicaid payments to states.

By Rebecca Pifer • Jan. 28, 2025

Philips to sell emergency care business

Investment firm Bridgefield Capital will buy the segment, which includes cardiac resuscitation and emergency care devices, for an undisclosed amount.

By Elise Reuter • Jan. 28, 2025

Neko Health raises $260M to expand body scan service, fund R&D

The company uses various medical devices to noninvasively check moles, the heart and more.

By Nick Paul Taylor • Jan. 28, 2025

FDA webpages on clinical trial diversity removed after Trump orders

The website changes raise concerns about “the interference of politics with the study and the practice” of science and medicine, a physician said.

By Elise Reuter • Jan. 27, 2025

Doctors expect Boston Scientific to lead PFA race, survey finds

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s current pause of U.S. cases, according to a poll by BTIG.

By Susan Kelly • Jan. 27, 2025

Sara Brenner named acting FDA commissioner

Brenner, who worked in the FDA’s Center for Devices and Radiological Health, will take the helm of the agency until a new leader is confirmed.

By Elise Reuter • Jan. 24, 2025

Intuitive execs cast wary eye on potential Trump tariffs

The surgical robot leader is watching developments under the new administration but has not included any tariff impact in its financial forecast.

By Susan Kelly • Jan. 24, 2025

Medtronic links closed-loop pain device to improvements after 12 months

The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at the company’s pain stimulation unit last quarter.

By Nick Paul Taylor • Jan. 24, 2025

Senate sets date to vet RFK Jr.’s nomination to lead HHS

The Senate Finance Committee will meet on Jan. 29 to discuss the confirmation of RFK Jr., whose stances on vaccines and abortion have raised questions from Democrats and Republicans alike.  

By Kristin Jensen • Jan. 23, 2025

Intuitive inks deals to sell robots in Italy, Spain and Portugal

Intuitive is buying businesses that distribute its da Vinci and Ion surgical robots to establish a direct presence in Italy, Spain, Portugal, Malta and San Marino.

By Nick Paul Taylor • Jan. 23, 2025

Trump eyes 10% China tariff hike by Feb. 1

The president floated a similar timeline for 25% tariffs on Canada and Mexico.

By Philip Neuffer • Jan. 23, 2025

Abbott expects to launch first PFA device outside of the US this year

CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.

By Elise Reuter • Jan. 22, 2025

Masimo picks Katie Szyman as CEO

Szyman led Edwards Lifesciences’ critical care unit for more than a decade before BD acquired the group last year. Her appointment “fits like a glove,” BTIG analyst Marie Thibault wrote.

By Susan Kelly • Jan. 22, 2025

AI in medtech is taking off. Here are 4 trends to watch in 2025.

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain around insurance coverage and generative AI.

By Elise Reuter • Jan. 22, 2025

Boston Scientific study meets goals for PFA in persistent AFib

The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation system in a larger group of patients with atrial fibrillation.

By Susan Kelly • Jan. 21, 2025

Medtronic names Thierry Piéton as CFO

Piéton fills an opening left by Karen Parkhill, who became HP’s CFO in August after eight years with Medtronic.

By Elise Reuter • Jan. 21, 2025

JPM25 recap: Robotics, PFA and OTC glucose sensors in the spotlight

CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the year ahead at the J.P. Morgan Healthcare Conference.

By Susan Kelly • Jan. 17, 2025

BD expands syringe, needle production capacity in Nebraska and Connecticut

BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.

By Ricky Zipp • Jan. 17, 2025

Tarver warns that US device supply chain vulnerabilities could harm patients

The new director of the FDA’s device center contrasted a European rule with the lack of mandatory reporting requirements for potential device shortages in the U.S.

By Nick Paul Taylor • Jan. 17, 2025

Hologic receives FDA warning letter over Biozorb implantable markers

Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.

By Elise Reuter • Updated Jan. 16, 2025